Vorinostat Completed Phase 2 Trials for Adult Giant Cell Glioblastoma / Adult Glioblastoma / Adult Gliosarcoma / Recurrent Adult Brain Tumor Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00641706Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme
NCT00238303Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme